Carregant...
Routine Clinical Anti-Platelet Agents Have Limited Efficacy in Modulating Hypershear-Mediated Platelet Activation Associated with Mechanical Circulatory Support
INTRODUCTION: Continuous flow ventricular assist devices (cfVADs) continue to be limited by thrombotic complications associated with disruptive flow patterns and supraphysiologic shear stresses. Patients are prescribed complex antiplatelet therapies, which do not fully prevent recurrent thromboembol...
Guardat en:
| Publicat a: | Thromb Res |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5879002/ https://ncbi.nlm.nih.gov/pubmed/29428715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2017.12.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|